23 April 2024

Earlier this year, the GMDN Agency established the Technical Advisory Group (TAG) committee, which represents medical device Regulators and Manufacturers that use the GMDN.

The TAG has invitees from Australia, Brazil, Canada, Colombia, Kenya, South Africa the United Kingdom, and the United States of America.

In March 2024, the TAG held its first meeting. Participating were representatives of medical device Regulators and Manufacturers from Australia, Brazil, the United Kingdom, and the United States of America.

The meeting provided valuable feedback, covering topics such as GMDN Term obsoletion management, systems & components, personalised medical devices, combination products and an update on sterility within the GMDN.

Dr Barry Daniels, Senior Clinical Lead at the GMDN Agency is leading the TAG. He said: “Our inaugural Technical Advisory Group meeting was a real success and a great opportunity to involve different stakeholders from across the medical device sector into one collaborative group in regard to the GMDN.”  

The Technical Advisory Group (TAG) meet regularly and provide advice to the Board of Trustees on matters of relevance to the satisfactory maintenance of the GMDN (Global Medical Device Nomenclature), including:

• Ways to ensure that the GMDN meets international requirements of regulatory bodies, industry, and other stakeholders as the primary working nomenclature.
• New and emerging international needs for nomenclatures.
• Means of ensuring that developing technologies are monitored and incorporated as appropriate.

As the GMDN Agency is a regulated charity, all TAG members are volunteers and not funded for activity linked with GMDN Agency governance.